Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (121-130 of 500) with videos related to

Pageof 50
Sort By:
Leukemia & Lymphoma|April 12, 2013
A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myelomaAmrita Y Krishnan, Shirong Wang, Joycelynne M Palmer, et al.
Blood|May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Molecular Cancer Therapeutics|April 5, 2015
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab VedotinRobert Chen, Jessie Hou, Edward Newman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factorsAuayporn Nademanee, Joycelynne M Palmer, Leslie Popplewell, et al.
Blood|September 25, 2004
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasAmrita Krishnan, Arturo Molina, John Zaia, et al.
Cancer|June 19, 2009
Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantationStephanie Campbell, Can-Lan Sun, Seira Kurian, et al.
Blood|October 7, 2011
Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantationSaro H Armenian, Can-Lan Sun, Tabitha Shannon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Transplant Immunology|March 4, 2014
Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipientsRyotaro Nakamura, Corinna La Rosa, Weimin Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft modelsTontanai Numbenjapon, Jianyi Wang, David Colcher, et al.
Pageof 50

Showing results (121-130 of 500) with videos related to

Sort By:
Pageof 50
Leukemia & Lymphoma|April 12, 2013
A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myelomaAmrita Y Krishnan, Shirong Wang, Joycelynne M Palmer, et al.
Blood|May 22, 2012
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Sandra H Thomas, et al.
Molecular Cancer Therapeutics|April 5, 2015
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab VedotinRobert Chen, Jessie Hou, Edward Newman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2011
High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factorsAuayporn Nademanee, Joycelynne M Palmer, Leslie Popplewell, et al.
Blood|September 25, 2004
Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomasAmrita Krishnan, Arturo Molina, John Zaia, et al.
Cancer|June 19, 2009
Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantationStephanie Campbell, Can-Lan Sun, Seira Kurian, et al.
Blood|October 7, 2011
Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantationSaro H Armenian, Can-Lan Sun, Tabitha Shannon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2014
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphomaRobert Chen, Joycelynne M Palmer, Ni-Chun Tsai, et al.
Transplant Immunology|March 4, 2014
Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipientsRyotaro Nakamura, Corinna La Rosa, Weimin Tsai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
Preclinical results of camptothecin-polymer conjugate (IT-101) in multiple human lymphoma xenograft modelsTontanai Numbenjapon, Jianyi Wang, David Colcher, et al.
Pageof 50